Study: Lifetime Cost of Vyjuvek Gene Therapy for DEB Could Be $15-$22 MillionFebruary 9, 2024PediatricsRare DiseasesWoundsBusiness of Medicine
FDA Approves Topical Gel For Wounds Associated With JEB and DEBDecember 22, 2023Rare DiseasesPediatricsWounds
New consensus guide on rare drug hypersensitivity reactionNovember 29, 2023Medical DermatologyWoundsMixed Topics
More phase 3 data support use of nemolizumab for prurigo nodularisNovember 2, 2023Medical DermatologyWoundsRare Diseases
Birch bark–derived treatment reduces daily dressings in patients with epidermolysis bullosaNovember 2, 2023WoundsPediatricsRare Diseases
A White male presented with a purulent erythematous edematous plaque with central necrosis and ulceration on his right flankSeptember 12, 2023Infectious DiseasesWounds
New AI-enhanced bandages poised to transform wound treatmentSeptember 7, 2023WoundsInfectious Diseases
Skin has different daytime and nighttime needs, emerging circadian research suggestsSeptember 7, 2023Aesthetic DermatologyWounds
Progress seen on five fronts for substantially improving treatment of epidermolysis bullosaJuly 27, 2023PediatricsRare DiseasesWounds
